These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34727195)

  • 21. Dppa2/4 Facilitate Epigenetic Remodeling during Reprogramming to Pluripotency.
    Hernandez C; Wang Z; Ramazanov B; Tang Y; Mehta S; Dambrot C; Lee YW; Tessema K; Kumar I; Astudillo M; Neubert TA; Guo S; Ivanova NB
    Cell Stem Cell; 2018 Sep; 23(3):396-411.e8. PubMed ID: 30146411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.
    Chari NS; Ivan C; Le X; Li J; Mijiti A; Patel AA; Osman AA; Peterson CB; Williams MD; Pickering CR; Caulin C; Myers JN; Calin GA; Lai SY
    J Natl Cancer Inst; 2020 Mar; 112(3):266-277. PubMed ID: 31124563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research and Clinical Significance of the Differentially Expressed Genes TP63 and LMO4 in Human Immunodeficiency Virus-Related Penile Squamous Cell Carcinoma.
    Xue W; Zheng X; Hu X; Zhang Y
    Am J Mens Health; 2021; 15(2):15579883211011380. PubMed ID: 33906487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromatin modulators as facilitating factors in cellular reprogramming.
    Luna-Zurita L; Bruneau BG
    Curr Opin Genet Dev; 2013 Oct; 23(5):556-61. PubMed ID: 23993229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rewiring of 3D Chromatin Topology Orchestrates Transcriptional Reprogramming and the Development of Human Dilated Cardiomyopathy.
    Feng Y; Cai L; Hong W; Zhang C; Tan N; Wang M; Wang C; Liu F; Wang X; Ma J; Gao C; Kumar M; Mo Y; Geng Q; Luo C; Lin Y; Chen H; Wang SY; Watson MJ; Jegga AG; Pedersen RA; Fu JD; Wang ZV; Fan GC; Sadayappan S; Wang Y; Pauklin S; Huang F; Huang W; Jiang L
    Circulation; 2022 May; 145(22):1663-1683. PubMed ID: 35400201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GATA3-dependent cellular reprogramming requires activation-domain dependent recruitment of a chromatin remodeler.
    Takaku M; Grimm SA; Shimbo T; Perera L; Menafra R; Stunnenberg HG; Archer TK; Machida S; Kurumizaka H; Wade PA
    Genome Biol; 2016 Feb; 17():36. PubMed ID: 26922637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogramming chromatin.
    Ehrensberger AH; Svejstrup JQ
    Crit Rev Biochem Mol Biol; 2012 Sep; 47(5):464-82. PubMed ID: 22757592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.
    Freberg CT; Dahl JA; Timoskainen S; Collas P
    Mol Biol Cell; 2007 May; 18(5):1543-53. PubMed ID: 17314394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tp63 in oral development, neoplasia, and autoimmunity.
    Romano RA; Solomon LW; Sinha S
    J Dent Res; 2012 Feb; 91(2):125-32. PubMed ID: 21646640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncarboxylated osteocalcin alleviates the inhibitory effect of high glucose on osteogenic differentiation of mouse bone marrow-derived mesenchymal stem cells by regulating TP63.
    Gong F; Gao L; Ma L; Li G; Yang J
    BMC Mol Cell Biol; 2021 Apr; 22(1):24. PubMed ID: 33906607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between the TP63 and SHH pathways is an important determinant of epidermal homeostasis.
    Chari NS; Romano RA; Koster MI; Jaks V; Roop D; Flores ER; Teglund S; Sinha S; Gruber W; Aberger F; Medeiros LJ; Toftgard R; McDonnell TJ
    Cell Death Differ; 2013 Aug; 20(8):1080-8. PubMed ID: 23686138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromatin reprogramming in breast cancer.
    Swinstead EE; Paakinaho V; Hager GL
    Endocr Relat Cancer; 2018 Jul; 25(7):R385-R404. PubMed ID: 29692347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional networks and chromatin remodeling controlling adipogenesis.
    Siersbæk R; Nielsen R; Mandrup S
    Trends Endocrinol Metab; 2012 Feb; 23(2):56-64. PubMed ID: 22079269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal inhibition of chromatin looping and enhancer accessibility during neuronal remodeling.
    Chen D; McManus CE; Radmanesh B; Matzat LH; Lei EP
    Nat Commun; 2021 Nov; 12(1):6366. PubMed ID: 34737269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AP-1 Takes Centre Stage in Enhancer Chromatin Dynamics.
    Madrigal P; Alasoo K
    Trends Cell Biol; 2018 Jul; 28(7):509-511. PubMed ID: 29778529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of potential nuclear reprogramming and differentiation factors by a novel selection method for cloning chromatin-binding proteins.
    Wang L; Zheng A; Yi L; Xu C; Ding M; Deng H
    Biochem Biophys Res Commun; 2004 Dec; 325(1):302-7. PubMed ID: 15522233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptive chromatin remodeling and transcriptional changes of the functional kinome in tumor cells in response to targeted kinase inhibition.
    East MP; Johnson GL
    J Biol Chem; 2022 Feb; 298(2):101525. PubMed ID: 34958800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming.
    Singhal N; Graumann J; Wu G; Araúzo-Bravo MJ; Han DW; Greber B; Gentile L; Mann M; Schöler HR
    Cell; 2010 Jun; 141(6):943-55. PubMed ID: 20550931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germ cell reprogramming.
    Kurimoto K; Saitou M
    Curr Top Dev Biol; 2019; 135():91-125. PubMed ID: 31155364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antiepidermal growth factor receptor antibody 528 on the proliferation and differentiation of head and neck cancer.
    Sturgis EM; Sacks PG; Masui H; Mendelsohn J; Schantz SP
    Otolaryngol Head Neck Surg; 1994 Nov; 111(5):633-43. PubMed ID: 7970803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.